STERIS plc

NYSE:STE 株式レポート

時価総額:US$23.6b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております

STERIS 過去の業績

過去 基準チェック /26

STERISは、平均年間1.6%の収益成長を遂げていますが、 Medical Equipment業界の収益は、年間 成長しています。収益は、平均年間8.7% 15%収益成長率で 成長しています。 STERISの自己資本利益率は8.8%であり、純利益率は10.7%です。

主要情報

15.2%

収益成長率

10.3%

EPS成長率

Medical Equipment 業界の成長8.9%
収益成長率13.5%
株主資本利益率8.8%
ネット・マージン10.7%
前回の決算情報30 Jun 2024

最近の業績更新

Recent updates

Steris: Dental Divestiture, Surgical Instrumentation Acquisition, But Overvalued

Sep 16

Earnings Tell The Story For STERIS plc (NYSE:STE)

Sep 13
Earnings Tell The Story For STERIS plc (NYSE:STE)

Steris: Q2 Numbers Solidify Buy Thesis

Aug 13

STERIS plc's (NYSE:STE) Intrinsic Value Is Potentially 59% Above Its Share Price

Aug 08
STERIS plc's (NYSE:STE) Intrinsic Value Is Potentially 59% Above Its Share Price

When Should You Buy STERIS plc (NYSE:STE)?

Jul 04
When Should You Buy STERIS plc (NYSE:STE)?

Is STERIS (NYSE:STE) Using Too Much Debt?

Jun 13
Is STERIS (NYSE:STE) Using Too Much Debt?

Steris: Moving On, Losing Its Teeth

Apr 14

STERIS plc's (NYSE:STE) Intrinsic Value Is Potentially 31% Above Its Share Price

Mar 29
STERIS plc's (NYSE:STE) Intrinsic Value Is Potentially 31% Above Its Share Price

STERIS (NYSE:STE) Has A Pretty Healthy Balance Sheet

Mar 07
STERIS (NYSE:STE) Has A Pretty Healthy Balance Sheet

Steris: Strong Healthcare Products Growth Coupled With Weak AST Business

Feb 17

STERIS plc's (NYSE:STE) Business Is Trailing The Industry But Its Shares Aren't

Feb 15
STERIS plc's (NYSE:STE) Business Is Trailing The Industry But Its Shares Aren't

An Intrinsic Calculation For STERIS plc (NYSE:STE) Suggests It's 23% Undervalued

Dec 17
An Intrinsic Calculation For STERIS plc (NYSE:STE) Suggests It's 23% Undervalued

Should You Investigate STERIS plc (NYSE:STE) At US$203?

Nov 24
Should You Investigate STERIS plc (NYSE:STE) At US$203?

Steris: Comprehensive Sterilization Portfolios Tailored To Procedure Volumes

Nov 08

We Think STERIS (NYSE:STE) Can Stay On Top Of Its Debt

Nov 06
We Think STERIS (NYSE:STE) Can Stay On Top Of Its Debt

Are STERIS plc (NYSE:STE) Investors Paying Above The Intrinsic Value?

Sep 18
Are STERIS plc (NYSE:STE) Investors Paying Above The Intrinsic Value?

Steris: Remains On Track For Strong Fiscal '24, Added Upsides From Operating Leverage

Sep 01

When Should You Buy STERIS plc (NYSE:STE)?

Aug 10
When Should You Buy STERIS plc (NYSE:STE)?

Steris: Continuing To Grow The Product Lineup

Jun 20

Steris falls 10% on Q3 revenue, profit miss, 2023 profit guidance lowered

Feb 09

Steris declares $0.47 dividend

Feb 01

These 4 Measures Indicate That STERIS (NYSE:STE) Is Using Debt Reasonably Well

Feb 01
These 4 Measures Indicate That STERIS (NYSE:STE) Is Using Debt Reasonably Well

Calculating The Intrinsic Value Of STERIS plc (NYSE:STE)

Dec 28
Calculating The Intrinsic Value Of STERIS plc (NYSE:STE)

Steris declares $0.47 dividend

Nov 02

STERIS (NYSE:STE) Seems To Use Debt Quite Sensibly

Nov 01
STERIS (NYSE:STE) Seems To Use Debt Quite Sensibly

Steris: Non-GAAP Valuations Supportive Of Substantial Upside

Sep 04

STERIS (NYSE:STE) Will Pay A Larger Dividend Than Last Year At $0.47

Aug 18
STERIS (NYSE:STE) Will Pay A Larger Dividend Than Last Year At $0.47

STERIS' (NYSE:STE) Dividend Will Be Increased To $0.47

Aug 04
STERIS' (NYSE:STE) Dividend Will Be Increased To $0.47

Steris Non-GAAP EPS of $1.90 in-line, revenue of $1.2B misses by $20M

Aug 02

Is STERIS (NYSE:STE) A Risky Investment?

Jul 19
Is STERIS (NYSE:STE) A Risky Investment?

Steris: Deleveraging Key Undercurrent, Valuation A Concern

Jun 12

収支内訳

STERIS の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。


収益と収入の歴史

NYSE:STE 収益、費用、利益 ( )USD Millions
日付収益収益G+A経費研究開発費
30 Jun 245,2355611,256105
31 Mar 245,1395511,227104
31 Dec 234,8851,0241,150101
30 Sep 234,7051,0071,095101
30 Jun 234,5635761,05098
31 Mar 234,5365571,07098
31 Dec 224,784-281,360101
30 Sep 224,777-81,361101
30 Jun 224,7733771,36995
31 Mar 224,2232851,11787
31 Dec 214,2482791,08179
30 Sep 213,84825095071
30 Jun 213,40728679368
31 Mar 213,10839769666
31 Dec 203,05743368366
30 Sep 203,02242467966
30 Jun 203,00341368566
31 Mar 203,03140870966
31 Dec 192,97639367664
30 Sep 192,89833668363
30 Jun 192,84031966562
31 Mar 192,78230464563
31 Dec 182,73026963765
30 Sep 182,69631662265
30 Jun 182,65130361863
31 Mar 182,62029161661
31 Dec 172,58524365059
30 Sep 172,57014463058
30 Jun 172,58212064059
31 Mar 172,61311065259
31 Dec 162,61614252358
30 Sep 162,58816756058
30 Jun 162,43113556957
31 Mar 162,23311154457
31 Dec 152,0429462957
30 Sep 151,89711351457
30 Jun 151,87013546855
31 Mar 151,84213545554
31 Dec 141,80713340252
30 Sep 141,73912343549
30 Jun 141,66012240049
31 Mar 141,61512938149
31 Dec 131,58513237549
30 Sep 131,56015237248

質の高い収益: STEは 高品質の収益 を持っています。

利益率の向上: STEの現在の純利益率 (10.7%)は、昨年(12.6%)よりも低くなっています。


フリー・キャッシュフローと収益の比較


過去の収益成長分析

収益動向: STEの収益は過去 5 年間で年間1.6%増加しました。

成長の加速: STEは過去 1 年間の収益成長がマイナスであったため、5 年間の平均と比較することはできません。

収益対業界: STEは過去 1 年間で収益成長率がマイナス ( -2.7% ) となったため、 Medical Equipment業界平均 ( 6.8% ) と比較することが困難です。


株主資本利益率

高いROE: STEの 自己資本利益率 ( 8.8% ) は 低い とみなされます。


総資産利益率


使用総資本利益率


過去の好業績企業の発掘